Invivotek Revenue and Competitors
Estimated Revenue & Valuation
- Invivotek's estimated annual revenue is currently $3.7M per year.
- Invivotek's estimated revenue per employee is $155,000
Employee Data
- Invivotek has 24 Employees.
- Invivotek grew their employee count by -23% last year.
Invivotek's People
Name | Title | Email/Phone |
---|---|---|
1 | Senior Scientist & Project Manager in Immuno-Oncology | Reveal Email/Phone |
2 | Senior Research Associate | Reveal Email/Phone |
3 | Research Associate | Reveal Email/Phone |
4 | Senior Scientist/Scientific Writer | Reveal Email/Phone |
5 | Senior Research Associate | Reveal Email/Phone |
6 | Research Assistant | Reveal Email/Phone |
7 | Senior Associate Scientist | Reveal Email/Phone |
Invivotek Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $8.5M | 55 | -21% | N/A | N/A |
#2 | $0.2M | 1 | 0% | N/A | N/A |
#3 | $8.5M | 55 | -29% | N/A | N/A |
#4 | $108.5M | 500 | 2% | N/A | N/A |
#5 | $0.8M | 5 | 0% | N/A | N/A |
#6 | $0.6M | 4 | 0% | N/A | N/A |
#7 | $14.7M | 68 | -23% | $206.4M | N/A |
#8 | $492.2M | 1503 | -15% | $568M | N/A |
#9 | $1.1M | 7 | -42% | N/A | N/A |
#10 | $4.5M | 29 | 0% | N/A | N/A |
What Is Invivotek?
Invivotek LLC, a member of Genesis Biotechnology Group® (GBG) is a global pre-clinical contract research organization (CRO) specializing in small animal studies for drug discovery and early optimization. Invivotek's facility was opened in 2012 and our first commercial project launched in 2013. Invivotek offers both custom and standard pre-clinical services for drug discovery and development programs for our clients. Invivotek’s portfolio includes animal models and bioassays designed to support in vivo testing of compounds related to Immunology and Inflammation, Oncology, Metabolic, and Cardiovascular diseases. Invivotek’s in vivo testing capabilities are supported by biochemical and molecular biology techniques as well as functional assays with primary cell cultures established from various mouse tissues under disease model and normal conditions. These assays provide tools to study the mechanism of action of various test therapeutics or potential target genes and to explore drug efficacy biomarkers. The collective experience across multiple therapeutic areas in conjunction with the business and project management skills of the team working in a state-of-the-art animal facility, position Invivotek as a leading provider of preclinical in vivo services.
keywords:N/AN/A
Total Funding
24
Number of Employees
$3.7M
Revenue (est)
-23%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.2M | 24 | 0% | N/A |
#2 | $4.3M | 25 | -4% | N/A |
#3 | $2.6M | 26 | 0% | N/A |
#4 | $2.5M | 26 | 8% | N/A |
#5 | N/A | 26 | 8% | N/A |